Etomidate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Etomidate Injection (injection) from Mylan Institutional, A Viatris Company with status Current. The shortage was first posted on Oct 5, 2022.
Shortage details
- Status
- Current
- Company
- Mylan Institutional, A Viatris Company
- Package NDC
- 67457-902-10
- Dosage Form
- Injection
- Presentation
- Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10)
- Initial Posting
- Oct 5, 2022